drugset / Trial / NCT03436719

Antibiotic Prophylaxis in Rectal Cancer Surgery: Oral With Intravenous Versus Intravenous Antibiotics.

NCT03436719

RandomizedParallel-groupOpen-labelPrevention

Summary

This is a randomized, controlled, parallel study to determine the efficiency of oral antibiotics in reduction of surgical site infection (SSI) in rectal cancer surgery.

Timeline

Start
2017-11-06
Primary completion
2020-07-31
Completion
2020-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Erythromycin Small molecule 500 mg Oral
Subject Metronidazole Small molecule 500 mg Oral
Background Cefoperazone Small molecule 1000 mg Intravenous
Background polyethylene glycol Other / unclassified

Indications